In Genotoxicity testing, to assay for genotoxic molecules, researchers assay for DNA harm in cells exposed to the hepatotoxic substrates. Techniques like in vitro and in vivo material medica Tests, Ames Assay and extra-terrestrial object Assay are developed to work out the chemical’s potential to cause DNA harm that will cause cancer. Genotoxicity tests are designed to find the medication that might cause genetic harm directly or indirectly by numerous mechanisms of action. Compounds that are known as genotoxic in these tests have the power to be human carcinogens and ultimately might induce cancer and nee defects. Genotoxicity testing of the latest chemical entities could be an integral half and is a regulative demand before the approval of the latest medication, in the Drug Development method. Late-stage failures may be reduced by distinctive genotoxicity at AN early stage in Drug Discovery instead of throughout regulative assessment.

  • Genotoxicity testing
  • Genotoxicity and mutagenicity
  • Pharmacogenetics & pharmacogenomics
  • In vitro and in vivo testing
  • Genotoxic medication

Related Conference of Genotoxicity

February 13-14, 2024

25th European Toxicology and Applied Pharmacology

Barcelona, Spain

Genotoxicity Conference Speakers